Literature DB >> 22362219

Clinical relevance of Ki67 gene expression analysis using formalin-fixed paraffin-embedded breast cancer specimens.

Satoko Yamamoto1, Mutsuko Ibusuki, Yutaka Yamamoto, Peifen Fu, Saori Fujiwara, Keiichi Murakami, Hirotaka Iwase.   

Abstract

BACKGROUND: Ki67 is a protein associated with cell cycle activity and shows a good correlation with the growth fraction, which has been proposed as a prognostic or predictive marker in breast cancer. In this study, we aimed to analyze the expression levels of Ki67 (MKI67) messenger RNA (mRNA) derived from formalin-fixed paraffin-embedded (FFPE) tissues for comparison with the immunohistochemical Ki67 labeling index, and investigate the correlation coefficients with clinical outcomes.
METHODS: We analyzed the data of Ki67 mRNA from FFPE and matched fresh-frozen (FF) tissues based on a real-time quantitative reverse-transcription polymerase chain reaction (RT-qPCR) assay system in 203 cases of primary invasive breast cancer.
RESULTS: The correlation between Ki67 mRNA expression of either FFPE or FF specimens and Ki67 labeling index was positive, as was the correlation between the FFPE and FF results (P < 0.0001). Ki67 mRNA expression of FFPE specimens was significantly associated with clinicopathological characteristics: tumor size, lymph node status, nuclear grade, hormone receptors, human epidermal growth factor receptor 2 (Her2) status, and tumor subtype. In prognostic results, Ki67 gene expression in the FFPE specimens revealed almost similar patterns of significance in Kaplan-Meier curves and univariate and multivariate relapse-free survival results as the Ki67 labeling index.
CONCLUSIONS: Gene expression analysis of Ki67 of FFPE specimens could be successfully performed using RT-qPCR, closely resembling the significant clinical characteristics of Ki67 labeling index. These results confirm that Ki67 gene expression of FFPE specimens has potential for evaluation of cell cycle activity of breast cancer specimens.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22362219     DOI: 10.1007/s12282-012-0332-7

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  20 in total

1.  Targeting breast cancer cells with a CuInS2/ZnS quantum dot-labeled Ki-67 bioprobe.

Authors:  Guang Sun; Wanying Xing; Ren Xing; Liu Cong; Sun Tong; Siyao Yu
Journal:  Oncol Lett       Date:  2017-12-14       Impact factor: 2.967

Review 2.  A Phenomic Perspective on Factors Influencing Breast Cancer Treatment: Integrating Aging and Lifestyle in Blood and Tissue Biomarker Profiling.

Authors:  Ainhoa Arana Echarri; Mark Beresford; John P Campbell; Robert H Jones; Rachel Butler; Kenneth J Gollob; Patricia C Brum; Dylan Thompson; James E Turner
Journal:  Front Immunol       Date:  2021-02-01       Impact factor: 7.561

3.  Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia.

Authors:  N Sandhöfer; K H Metzeler; M Rothenberg; T Herold; S Tiedt; V Groiß; M Carlet; G Walter; T Hinrichsen; O Wachter; M Grunert; S Schneider; M Subklewe; A Dufour; S Fröhling; H-G Klein; W Hiddemann; I Jeremias; K Spiekermann
Journal:  Leukemia       Date:  2014-10-17       Impact factor: 11.528

4.  Pan-cancer analysis of the extent and consequences of intratumor heterogeneity.

Authors:  Noemi Andor; Trevor A Graham; Marnix Jansen; Li C Xia; C Athena Aktipis; Claudia Petritsch; Hanlee P Ji; Carlo C Maley
Journal:  Nat Med       Date:  2015-11-30       Impact factor: 53.440

5.  [18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in mice.

Authors:  Mette Munk Jensen; Kamille Dumong Erichsen; Camilla Bardram Johnbeck; Fredrik Björkling; Jacob Madsen; Peter Buhl Jensen; Maxwell Sehested; Liselotte Højgaard; Andreas Kjær
Journal:  BMC Cancer       Date:  2013-04-01       Impact factor: 4.430

6.  An integrative analysis of PIK3CA mutation, PTEN, and INPP4B expression in terms of trastuzumab efficacy in HER2-positive breast cancer.

Authors:  Aiko Sueta; Yutaka Yamamoto; Mutsuko Yamamoto-Ibusuki; Mitsuhiro Hayashi; Takashi Takeshita; Satoko Yamamoto; Hirotaka Iwase
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

7.  Abnormal expression of the Notch and Wnt/β-catenin signaling pathways in stem-like ALDHhiCD44+ cells correlates highly with Ki-67 expression in breast cancer.

Authors:  Junwei Cui; Peng Li; Xiaoling Liu; Hui Hu; Wei Wei
Journal:  Oncol Lett       Date:  2015-02-09       Impact factor: 2.967

8.  In vivo imaging of therapy response to a novel pan-HER antibody mixture using FDG and FLT positron emission tomography.

Authors:  Carsten H Nielsen; Mette M Jensen; Lotte K Kristensen; Anna Dahlman; Camilla Fröhlich; Helle J Jacobsen; Thomas T Poulsen; Johan Lantto; Ivan D Horak; Michael Kragh; Andreas Kjaer
Journal:  Oncotarget       Date:  2015-11-10

9.  Bridging cancer biology with the clinic: relative expression of a GRHL2-mediated gene-set pair predicts breast cancer metastasis.

Authors:  Xinan Yang; Prabhakaran Vasudevan; Vishwas Parekh; Aleks Penev; John M Cunningham
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

10.  CD38 Expression in a Subset of Memory T Cells Is Independent of Cell Cycling as a Correlate of HIV Disease Progression.

Authors:  Daniela Würsch; Christopher E Ormsby; Dámaris P Romero-Rodríguez; Gustavo Olvera-García; Joaquín Zúñiga; Wei Jiang; Santiago Pérez-Patrigeon; Enrique Espinosa
Journal:  Dis Markers       Date:  2016-03-14       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.